Ironwood Pharma Inc Class A (IRWD)
R&D to Revenue
32.12%
Fiscal year · Period ending:
IRWD R&D to Revenue
Latest reported32.12%period ending
Latest reported32.12%period ending
IRWD FY R&D/Revenue (1131.94% → 32.12%)
Latest values, visible window
High-resolution chart · PNG
IRWD r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 32.1242% | |
| 31.7068% | |
| 26.22% | |
| 10.7807% | |
| 17.0162% | |
| 22.6077% | |
| 28.5341% | |
| 48.0335% | |
| 49.6949% | |
| 50.9175% | |
| 72.713% | |
| 133.3011% | |
| 447.4367% | |
| 75.526% | |
| 130.6994% | |
| 176.6058% | |
| 235.1449% | |
| 269.2159% | |
| 547.0757% | |
| 1,131.9427% |